The Patent Finder
US

A19-144, A2-73 and Certain Anticholinesterase Inhibitor Compositions and Method for Anti-Seizure Therapy

US 12,594,256 In force
OverviewFamilyAssignmentsSources & methods

Term ends Oct 19, 2035 · High confidence

Filed May 18, 2023 as application 18/320,159 · Granted Apr 7, 2026
Base term plus 244 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
20 years from filing
2015 2035
Clock starts
Oct 19, 2015
Term ends
Oct 19, 2035
Granted
Apr 7, 2026
base term Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
244
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 10,813,907, US 11,690,821.
0 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
6
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term runs 244 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 0 of 2 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Oct 19, 2015, when application PCT/US2015/056172, the earliest non-provisional in its chain, was filed (this one was filed May 18, 2023)Oct 19, 2035High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+244 days, USPTO patent term adjustment recordJun 19, 2036High confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 10,813,907, US 11,690,821)capped to Oct 19, 2035High confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events0 of 2 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderOct 19, 2035High confidence

This family

Application PCT/US2015/056172PCT application
no patent term
no patent term
US 10,441,563In force
Oct 2035
Oct 2035
US 10,813,907In force
Oct 2035
Oct 2035
US 11,690,821In force
Oct 2035
Oct 2035
US 12,594,256this patent
Oct 2035
Oct 2035
Application 19/568,331Pending
not computed
not computed
The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
May 19, 2023
Reel 63703, frame 271
Missling, Christopher U.; Durrant, CameronAnavex Life Sciences Corp.Assignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited